CoChat

State-of-the-art application of nanoparticles in radiotherapy: a platform for synergistic effects in cancer treatment

Open access

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Radiotherapy (RT) is a gold standard cancer treatment worldwide. However, RT has limitations and many side effects. Nanoparticles (NPs) have exclusive properties that allow them to be used in cancer therapy. Consequently, the combination of NP and RT opens up a new frontier in cancer treatment. Among NPs, gold nanoparticles (GNPs) are the most extensively studied and are considered ideal radiosensitizers for radiotherapy due to their unique physicochemical properties and high X‑ray absorption. This review analyzes the various roles of NPs as radiosensitizers in radiotherapy of glioblastoma (GBS), prostate cancer, and breast cancer and summarizes recent advances. Furthermore, the underlying mechanisms of NP radiosensitization, including physical, chemical, and biological mechanisms, are discussed, which may provide new directions for next-generation GNP optimization and clinical transformation. Graphic abstract

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00066-024-02301-y

Cites

Statistics

Figures

Fig. 1 Illustration of the mechanisms of radiation damage. In the case of the direct effect, IR directly damages the DNA, which, if unrepaired, results in cell death or permanent growth arrest. In the case of the indirect effect, ROS are formed by the radiolysis of a large amount of water and oxygen, and the ROS then damage the DNA. There are many types of DNA damage, such as base change, SSB, DSB, and cross-linkage with protein or with other DNA molecules. (Adapted from [12]). IR ion radiation, ROS reactive oxygen species, SSB single strand break, DSB double strand break
Fig. 1 Illustration of the mechanisms of radiation damage. In the case of the direct effect, IR directly damages the DNA, which, if unrepaired, results in cell death or permanent growth arrest. In the case of the indirect effect, ROS are formed by the radiolysis of a large amount of water and oxygen, and the ROS then damage the DNA. There are many types of DNA damage, such as base change, SSB, DSB, and cross-linkage with protein or with other DNA molecules. (Adapted from [12]). IR ion radiation, ROS reactive oxygen species, SSB single strand break, DSB double strand breakCC BY · PubMed Central
Fig. 2 Differential physicochemical events distinguish FLASH from CONV irradiation. (Adapted from [14]). ROS reactive oxygen species
Fig. 2 Differential physicochemical events distinguish FLASH from CONV irradiation. (Adapted from [14]). ROS reactive oxygen speciesCC BY · PubMed Central
Fig. 3 Schematic illustration of a nanoparticle-enhanced radiotherapy system. (Adapted from [43])
Fig. 3 Schematic illustration of a nanoparticle-enhanced radiotherapy system. (Adapted from [43])CC BY · PubMed Central
Fig. 4 Tumor-targeted bismuth nanoparticles enhanced by X‑ray irradiation for breast cancer. (Adapted from [59]). RBC red blood cell, F-RBC-Bismuth NPs folate red blood cell bismuth nanoparticles
Fig. 4 Tumor-targeted bismuth nanoparticles enhanced by X‑ray irradiation for breast cancer. (Adapted from [59]). RBC red blood cell, F-RBC-Bismuth NPs folate red blood cell bismuth nanoparticlesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 66 · Cited by 16

Research works printed but not linked: 3

  1. Chhikara BS, Parang K (2023) Global cancer statistics 2022: the trends projection analysis, chemical. Biol Lett 10(1):451–451
  2. Xia L, Wen L, Meng X, Zhou N, Guo X, Liu T, Xu X, Wang F, Zhu H, Yang Z (2021) Application analysis of 124I-PPMN for enhanced retention in tumors of prostate cancer xenograft mice. Int J Nanomedicine 16:7685–7695 · DOI
  3. Cheng MHY, Overchuk M, Rajora MA, Lou JWH, Chen Y, Pomper MG, Chen J, Zheng G (2022) Targeted theranostic 111in/Lu-Nanotexaphyrin for SPECT imaging and photodynamic therapy. Mol Pharmaceutics 19(6):1803–1813 · DOI

Metadata

Authors
Mostafavi, M., Ghazi, F., Mehrabifard, M., Alivirdiloo, V., Hajiabbasi, M., Rahimi, F., Mobed, A., Taheripak, G., Ramezani Farani, M., Huh, Y. S., Bakhtiyari, S., & Alipourfard, I.
Affiliations
  • Shahid Beheshti University of Medical Sciences (IR)
  • Tabriz University of Medical Sciences (IR)
  • Hormozgan University of Medical Sciences (IR)
  • Mazandaran University of Medical Sciences (IR)
  • Islamic Azad University Tonekabon (IR)
  • Iran University of Medical Sciences (IR)
  • Inha University (KR)
  • Medical University of Ilam (IR)
  • Institute of Physical Chemistry (PL)
Corresponding author
Alipourfard, Iraj
Venue
Strahlentherapie und Onkologie
Published
2024-10-04
Volume
201
Issue
6
Pages
577-588
ISSN
  • 0179-7158 (ISSN-L)
  • 1439-099X
OpenAlex
W4403115845
Cited by
16
References
66
Citations by year
2026: 8 · 2025: 7 · 2024: 1
FWCI
1.20
Type
journal article
Language
en
Open access
Licence
Locations
  • Strahlentherapie und Onkologie (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
nanoparticles, gold nanoparticles, radiosensitizers, radiotherapy, synergistic cancer therapy, glioblastoma, prostate cancer, breast cancer, radiosensitization mechanism, X-ray absorption, nanoparticle radiosensitization
MeSH terms
Animals, Breast Neoplasms, Glioblastoma, Gold, Humans, Neoplasms, Prostatic Neoplasms, Radiation-Sensitizing Agents, Radiotherapy, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: State-of-the-art application of nanoparticles in radiotherapy: a platform for synergistic effects in cancer treatment. https://app.cochat.ai/papers/10.1007/s00066-024-02301-y
The paper
Mostafavi, M., Ghazi, F., Mehrabifard, M., Alivirdiloo, V., Hajiabbasi, M., Rahimi, F., Mobed, A., Taheripak, G., Ramezani Farani, M., Huh, Y. S., Bakhtiyari, S., & Alipourfard, I. (2025). State-of-the-art application of nanoparticles in radiotherapy: a platform for synergistic effects in cancer treatment. Strahlentherapie und Onkologie. https://doi.org/10.1007/s00066-024-02301-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.